نتائج البحث - "Liver - Diseases"

1

miRNAs in liver diseases

المساهمون: Castro, Rui E., Rodrigues, Cecília M. P., Repositório da Universidade de Lisboa

مصطلحات موضوعية: Alcoholic liver disease, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, miRNAs, Non-alcoholic fatty liver disease, Mestrado Integrado - 2013, Domínio/Área Científica::Ciências Médicas::Ciências da Saúde

وصف الملف: application/pdf

الاتاحة: http://hdl.handle.net/10451/46150

View record in RCAAP

2

Report

Screening for Chronic Liver Diseases in General Population (HEPGEN)

المؤلفون: On-call medical home (MMG) Clermont-Hérault, Medical office Montpeyroux, Medical office Clermont-Hérault, Medical office Aniane

المصدر: Non-invasive Screening for Chronic Liver Diseases in the General Population. A Prospective Study
Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008 Apr;134(4):960-74. doi: 10.1053/j.gastro.2008.01.034. Epub 2008 Jan 18.
de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30. Erratum In: J Hepatol. 2022 Jul;77(1):271. doi: 10.1016/j.jhep.2022.03.024.
Gines P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A; LiverScreen Consortium Investigators. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10.
Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, Becker U, Bendtsen F. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut. 2004 May;53(5):750-5. doi: 10.1136/gut.2003.019984.
Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 1995 Oct 14;346(8981):987-90. doi: 10.1016/s0140-6736(95)91685-7.
Marshall AD, Micallef M, Erratt A, Telenta J, Treloar C, Everingham H, Jones SC, Bath N, How-Chow D, Byrne J, Harvey P, Dunlop A, Jauncey M, Read P, Collie T, Dore GJ, Grebely J. Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study. Int J Drug Policy. 2015 Oct;26(10):984-91. doi: 10.1016/j.drugpo.2015.07.002. Epub 2015 Jul 16.
Mwamba-Kalambayi P, Etienne A, Chirpaz E, Gelu-Simeon M, Cuissard L, Deloumeaux J, et al. Étude comparative de la fréquence des hépatites B et C chez les personnes nouvellement diagnostiquées pour carcinome hépatocellulaire en France métropolitaine et dans les départements et régions d'outre-mer, 2015-2019. Bull Epidémiol Hebd. 2022;(3-4): 85-94.
Oberti F, Cailliez E, Hubert I et al. Dépistage de la fibrose hépatique en populations générale et de médecine générale (étude DEFIH). Gastroenterol Clin Biol 2006;30:A7.

View record in ClinicalTrials.gov

3

Report

Percutaneos Liver Biopsy in Pediatric Patient : Diagnostic Significance and Pattern of Liver Diseases

المساهمون: Mohrail nagy naeim kerolos, Assiut government

المصدر: Percutaneos Liver Biopsy in Pediatric Patient : Diagnostic Significance and Pattern of Liver Diseases

View record in ClinicalTrials.gov

4

Report

Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia

المساهمون: Saadiea Abdo Bedir Eid, Principal investigator

المصدر: Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia

View record in ClinicalTrials.gov

5

Report

Aromatherapy Massage for Itching Management in Liver Diseases

المساهمون: Amine Terzi, Asst. Prof.

المصدر: The Effect of Aromatherapy Massage on Itching, Comfort, Skin PH Level, and Skin Moisture in Liver Diseases: Randomised Controlled Trial

View record in ClinicalTrials.gov

6

Report

'Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases'. (LivMOD)

المصدر: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

View record in ClinicalTrials.gov

7

Report

Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study

المصدر: Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study

View record in ClinicalTrials.gov

8

Academic Journal

AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

المصدر: Nature Medicine. 30(10)

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/3x19c7q6
https://escholarship.org/content/qt3x19c7q6/qt3x19c7q6.pdf

View record in eScholarship

9

Report

Electrocardiogram-based diagnosis of liver diseases: an externally validated and explainable machine learning approach

المؤلفون: Alcaraz, Juan Miguel Lopez, Haverkamp, Wilhelm, Strodthoff, Nils

مصطلحات موضوعية: Computer Science - Machine Learning, Electrical Engineering and Systems Science - Signal Processing

URL الوصول: http://arxiv.org/abs/2412.03717

View record in Arxiv

10

Report

Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases (MASLD)

المساهمون: Lu Chen, MS

المصدر: Efficacy and Safety of Hyperbaric Oxygen Therapy in Adult Metabolic Dysfunction-associated Steatotic Liver Diseases (MASLD) Patients : a Randomized Controlled Trial

View record in ClinicalTrials.gov

11

Report

Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data (LivSPECTRUS)

المؤلفون: University Hospital Dresden, University of Leipzig

المساهمون: Moritz Herzog, Principal Investigator

المصدر: Acquisition and Frequency Spectroscopic Evaluation of Broadband Clinical Ultrasound Raw Data for Liver Cirrhosis and Focal Pathologies Using Neural Networks for Tissue and Pathology Differentiation

Other URLs: https://digitalhealth.tu-dresden.de/projects/hybridecho/spectrus/

View record in ClinicalTrials.gov

12

Report

Mobile Chat Messaging for Alcohol Reduction in Patients with Chronic Liver Diseases

المؤلفون: Health and Medical Research Fund

المساهمون: Tzu Tsun Luk, Research Assistant Professor

المصدر: Mobile Chat Messaging Plus Screening-based Brief Alcohol Intervention for Patients with Chronic Liver Diseases: a Pilot Randomised Controlled Trial

View record in ClinicalTrials.gov

13

Report

Fructose and Liver Diseases in Youth: Help Them FLY (FLY)

المؤلفون: Alberta Health services, Canadian Institutes of Health Research (CIHR)

المصدر: Dietary Fructose as a Mediator to Altered Liver Energy Metabolism and Oxidative Stress in Youth With Non-alcoholic Fatty Liver Disease: HELP THEM FLY.

View record in ClinicalTrials.gov

14

Report

Investigating Myosteatosis in Steatotic Liver Diseases (MYO-SLD)

المؤلفون: Fonds National de la Recherche Scientifique, Concerted Research Action

المصدر: MYO-SLD : a Prospective Study to Determine the Phenotype of Muscle Fat Accumulation in a Cohort of Patients With SLD as to Confirm the Association Between Muscle Composition and Texture and the Phenotype of Liver Disease
Linge J, Nasr P, Sanyal AJ, Dahlqvist Leinhard O, Ekstedt M. Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD. JHEP Rep. 2022 Dec 24;5(3):100663. doi: 10.1016/j.jhepr.2022.100663. eCollection 2023 Mar.
Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008 Oct;49(4):608-12. doi: 10.1016/j.jhep.2008.06.018. Epub 2008 Jul 9.
Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA. 2021 Jul 13;326(2):165-176. doi: 10.1001/jama.2021.7683.
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gomez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
Nachit M, Lanthier N, Rodriguez J, Neyrinck AM, Cani PD, Bindels LB, Hiel S, Pachikian BD, Trefois P, Thissen JP, Delzenne NM. A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients. JHEP Rep. 2021 Jun 15;3(4):100323. doi: 10.1016/j.jhepr.2021.100323. eCollection 2021 Aug.
Nachit M, Kwanten WJ, Thissen JP, Op De Beeck B, Van Gaal L, Vonghia L, Verrijken A, Driessen A, Horsmans Y, Francque S, Leclercq IA. Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity. J Hepatol. 2021 Aug;75(2):292-301. doi: 10.1016/j.jhep.2021.02.037. Epub 2021 Apr 15.
Henin G, Loumaye A, Leclercq IA, Lanthier N. Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease. JHEP Rep. 2023 Nov 14;6(2):100963. doi: 10.1016/j.jhepr.2023.100963. eCollection 2024 Feb.